Pimozide
CAS 2062-78-4 6 FDA-DMF suppliersSmall Molecule
Overview
Pimozide is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1423).
API suppliers (8)
Suppliers of Pimozide backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.
- UNIMARK REMEDIES LTD1 active DMF
- PH HEALTH LTD1 active DMF
- UNIMARK REMEDIES LTD1 active DMF
- UNIMARK REMEDIES LTD1 active DMF
- PH HEALTH LTD1 active DMF
- Organon & Co.United States
- JANSSEN RESEARCH FDN
- ALIVUS LIFE SCIENCES LTD
Patent & exclusivity (US)
Per the FDA Orange Book (4 approved US products), the latest listed US patent on Pimozide expires — and exclusivity 17 Oct 2026. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- 3-[1-[4,4-bis(4-fluorophenyl)butyl]piperidin-4-yl]-1H-benzimidazol-2-one
- Canonical SMILES
- C1CN(CCC1N2C3=CC=CC=C3NC2=O)CCCC(C4=CC=C(C=C4)F)C5=CC=C(C=C5)F
- InChIKey
- YVUQSNJEYSNKRX-UHFFFAOYSA-N
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.